Accessibility Menu
 
Gamida Cell logo

Gamida Cell

(OTC) GMDA

Current PriceN/A
Market CapN/A
Since IPO (2018)-100%
5 Year-100%
1 Year-99%
1 Month+10%

Gamida Cell Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$2.67M

Net Income (TTM)

$22.09M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Gamida Cell

Industry

Biotechnology

Employees

148

CEO

Abigail L. Jenkins

Headquarters

Jerusalem, 91340, IL

GMDA Financials

Key Financial Metrics (TTM)

Gross Margin

-95%

Operating Margin

-41%

Net Income Margin

-35%

Return on Equity

11%

Return on Capital

-95%

Return on Assets

-62%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$1.69M

Operating Income

$73.04M

EBITDA

$53.38M

Operating Cash Flow

$79.12M

Capital Expenditure

$1.08M

Free Cash Flow

$80.20M

Cash & ST Invst.

$49.61M

Total Debt

$82.94M

Gamida Cell Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2024YOY CHG

Revenue

$890.00K

N/A

Gross Profit

$2.72M

-2464.2%

Gross Margin

-3.05%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

143

N/A

Net Income

$19.95M

+189.3%

EBITDA

$24.01M

-23.3%

Quarterly Fundamentals

Name
Q1 2024YOY CHG

Net Cash

$53.31M

-8.9%

Accounts Receivable

$1.03M

N/A

Inventory

$1.97M

N/A

Long Term Debt

$1.85M

-98.0%

Short Term Debt

$76.24M

+3561.7%

Return on Assets

-61.65%

N/A

Return on Invested Capital

-94.87%

N/A

Free Cash Flow

$23.09M

+0.1%

Operating Cash Flow

$23.00M

-3.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
APTOAptose Biosciences Inc.
$1.71+100.00%
GRTSGritstone bio, Inc.
$0.03-31.78%
NBRVFNabriva Therapeutics plc
$0.00+0.00%
TNFATNF Pharmaceuticals, Inc.
$5.20+48.15%

Trending Stocks

Symbol / CompanyPricePrice Chg
CYCNCyclerion Therapeutics
$6.38+3.12%
INTCIntel
$48.03+0.09%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.23+0.04%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.45-0.01%

Questions About GMDA

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.